A Swedish study finds AI-supported screening detects 29% more cancers without increasing false positives, while cutting radiologists’ workload by 44%.
Study: Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study. Image Credit: Gorodenkoff/Shutterstock.com
In a recent study published in The Lancet Digital Health, researchers examined the performance of cancer screening in the mammography screening with artificial intelligence (MASAI) trial.
Background
Breast cancer is a heterogeneous disease that ranges from indolent to aggressive forms. Cancer characterization based on size, morphology, molecular subtype,…